Ericsson, Nokia combine on research for 6G video
Ericsson and Nokia Collaborate on 6G Video Research Nokia, Ericsson, and the Fraunhofer Heinrich Hertz Institute have presented a proof-of-concept for a technology designed to address 6G v…
Vesper Solar 600 MW Texas project shows how an agrivoltaics mindset can unlock prime sites
Vesper Solar 600 MW Texas Project The Vesper Solar 600 MW Texas project demonstrates how an agrivoltaics mindset can unlock prime sites fo…
South Africa: SAHPRA Approves Lenacapavir for HIV Prevention
South Africa Approves Lenacapavir for HIV Prevention South Africa's Health Product Regulatory Authority (SAHPRA) has approved lenacapavir,…
Abbott Told to Provide Prescribing Details, Supporting Data for Triamcinolone Hexacetonide Pre-Filled Syringe
Abbott Directed to Provide Prescribing Details for Triamcinolone Hexacetonide Pre-Filled Syringe The Subject Expert Committee (SEC) under …
Waaree lands 692MW solar module deals across India and the US
Waaree Secures 692MW Solar Module Deals Waaree Energies, an Indian solar manufacturer, has secured four solar module supply contracts tota…
Chick-fil-A sparks debate after unveiling hospital vending machine
Chick-fil-A Introduces Hospital Vending Machine Fast-food giant Chick-fil-A has launched its first-ever vending machine, sparking debate a…
Kymera Therapeutics, Inc.: Kymera Therapeutics Presents New Preclinical Data for KT-579, a First-in-Class, Oral IRF5 Degrader, at the American College of Rheumatology Annual Meeting
Kymera Therapeutics Presents New Preclinical Data for KT-579 Kymera Therapeutics, Inc., a clinical-stage biopharmaceutical company, announ…
Which Non-League sides will take part in the Isuzu FA Trophy Second Round Proper? - The Non-League Football Paper
Isuzu FA Trophy Second Round Proper Draw Confirmed The draw for the Isuzu FA Trophy Second Round Proper has been confirmed, with 40 ties s…
Older Patients and Women Bear the Brunt of CTD-ILD Burden
CTD-ILD Burden on Older Patients and Women The incidence and prevalence of Connective Tissue Diseases with Interstitial Lung Disease (CTD-…
Zenas BioPharma Announces Positive Results from Phase 2 MoonStone Trial of Obexelimab in Relapsing Multiple Sclerosis
Zenas BioPharma Announces Positive Results from Phase 2 MoonStone Trial Zenas BioPharma, a clinical-stage global biopharmaceutical company…
Saudi Railway Company, Ericsson ink 5G pact
Saudi Railway Company and Ericsson Partner on 5G Technology The Saudi Railway Company (SAR) has signed a memorandum of understanding (MoU)…